Sunday 10 December 2023 - 20:57
In Business 43 Years - Since 1980
NOTE: our usual phone and fax lines are down, due to a dispute between our landlord and Verizon.
In the meantime, please use this mobile phone number: 978-715-9327 and this fax number: 781-415-0695
The 25% Discount for Shopping Cart Purchases is now PERMANENT !!
For Online Shopping Cart Orders Only
In-Stock Sizes Only
See Check-out Page For Further Details
FREE SHIPPING TO THE U.S. AND 32 OTHER COUNTRIES! [Read more].
Search:
S-7800 SB431542, Free Base, >99%
- Size
- US $
- €
- £
- ¥
- 5 mg
- 48
- 44
- 38
- 7,000
- In stock
- 10 mg
- 62
- 57
- 49
- 9,000
- In stock
- 25 mg
- 108
- 100
- 86
- 15,600
- In stock
- 50 mg
- 191
- 177
- 152
- 27,700
- In stock
- 100 mg
- 336
- 311
- 267
- 48,700
- In stock
- 200 mg
- 598
- 554
- 476
- 86,600
- In stock
- 500 mg
- 959
- 889
- 764
- 138,900
- In stock
- 1 g
- 1,550
- 1,438
- 1,235
- 224,500
- In stock
Note: Our Euro, Pound, and Yen prices are revised regularly to account for currency exchange rate fluctuations.
To receive a Formal Quotation for catalog sizes of this product and/or any other products, please add them to your shopping cart and click on the “REQUEST A QUOTATION” box.
Click Here to Request a Quotation for Larger Quantities
Free Shipping and Handling to the U.S. and 32 Other Countries
- M.W. 384.39
- C22H16N4O3
- [301836-41-9]
Solubility: DMSO.
- SB-431542 selectively inhibited Smad3 phosphorylation, with an IC50 of 94 nM. It also blocked TGF-beta1-induced nuclear Smad3 localization. Laping N.J., et al. "Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542." Mol. Pharmacol. 62: 58-64 (2002).
- SB-431542 is a potent inhibitor of activin receptor-like kinase (ALK)5 (the TGF-beta type I receptor). It also inhibits the activin type I receptor ALK4 and the nodal type I receptor ALK7. It has no major effect on the other ALK family members that recognize bone morphogenetic proteins (BMPs). Inman G.J., et al. "SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7." Mol. Pharmacol. 62: 65-74 (2002).
- SB-431542 is a specific inhibitor of TGF-beta receptor kinase. It inhibits TGF-beta-induced transcription, gene expression and tumor-promoting effects. Interestingly, SB-431542 promoted anchorage independent growth of cells which were growth-inhibited by TGF-beta, whereas it inhibited colony formation by cells which were growth-promoted by TGF-beta. Halder S.K., et al. "A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers." Neoplasia. 7: 509-521 (2005).
- Related CAS numbers: 1049727-65-2 for the monohydrate.
- Sold for laboratory or manufacturing purposes only; not for human, veterinary, food, or household use.
- This product is offered for R&D use in accordance with (i) 35 USC 271(e)+A13(1) in the U.S.; (ii) Section 69.1 of Japanese Patent Law in Japan; (iii) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (v) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (vi) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (vii) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (viii) such similar laws and rules as may apply in various other countries.
- Not available in some countries; not available to some institutions; not available for some uses.
